A trial looking at different drugs for non small cell lung cancer (National Lung Matrix Trial)

Overview

Cancer types:

Lung cancer, Non small cell lung cancer (NSCLC), Secondary cancers

Status:

Results

Phase:

Phase 2

Details

This trial looked at a number of different drugs to treat non small cell lung cancer (NSCLC). The treatment people had depended on the gene changes in their cancer cells.

The trial was supported by Cancer Research UK. It was open for people to join between 2015 and 2021. The research team have published some results but they plan to publish more in the future.

Recruitment start: 31 March 2015

Recruitment end: 31 October 2021